PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced that the large international randomized BIOADAPTOR RCT trial of the company’s DynamX ® ...
MILPITAS, Calif.--(BUSINESS WIRE)--Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced that data from its BIOADAPTOR RCT randomized controlled trial (RCT), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback